Literature DB >> 29570929

Multicentre international experience of 532-nm laser photoselective vaporization with GreenLight XPS in men with very large prostates.

Roger Valdivieso1, Pierre-Alain Hueber1, Malek Meskawi1, Eric Belleville1, Khaled Ajib1, Franck Bruyere2, Alexis E Te3, Bilal Chughtai3, Dean Elterman4, Vincent Misrai5, Kevin C Zorn1.   

Abstract

OBJECTIVES: To describe peri-operative results, functional outcomes and complications of laser photoselective vaporization, using the GreenLight system, of prostate glands ≥200 mL in volume.
METHODS: Retrospective analysis of a prospectively maintained multicentre database was performed to select a subgroup of patients with very large prostates (volume ≥200 mL) treated with the GreenLight XPS laser. A subgroup of patients with prostate volumes 100-200 mL was used for comparison. International Prostate Symptom Score, maximum urinary flow rate, postvoid residual urine volume and prostate-specific antigen levels were measured at 6, 12, 24, 36 and 48 months. Durability was evaluated using benign prostatic hyperplasia re-treatment rate at 12, 24 and 36 months. Additionally, complications were recorded using Clavien-Dindo classification.
RESULTS: A total of 33 patients (38%) had prostates ≥200 mL. Baseline characteristics were similar between patients with prostates ≥200 mL and those with prostates 100-200 mL. Patients with very large prostates (≥200 mL) had longer operating times (129 vs 93 min), less energy delivered, a greater number of fibres used (3 vs 2) and a higher conversion rate to transurethral resection of the prostate (16% vs 4%). In terms of complications and functional outcomes, we did not find any differences between the groups. Retreatment rate was also comparable.
CONCLUSIONS: Our results show that PVP GreenLight XPS-180W is an acceptable technique for very large prostates (≥200 mL); however, operating times, energy delivery, fibres used and conversion to TURP are a concern in this particular subgroup. This should be used for patient counselling and surgery planning.
© 2018 The Authors BJU International © 2018 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  180W and very large glands; Benign prostatic hyperplasia; GreenLight; XPS; photoselective vaporization

Mesh:

Year:  2018        PMID: 29570929     DOI: 10.1111/bju.14208

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  13 in total

Review 1.  [Surgical treatment of benign prostatic hyperplasia-resection, vaporization or enucleation?]

Authors:  M Rieken; T R W Herrmann; C Füllhase
Journal:  Urologe A       Date:  2019-03       Impact factor: 0.639

2.  Aquablation among novice users in Canada: A WATER II subpopulation analysis.

Authors:  Kevin C Zorn; S Larry Goldenberg; Ryan Paterson; Alan So; Dean Elterman; Naeem Bhojani
Journal:  Can Urol Assoc J       Date:  2018-10-15       Impact factor: 1.862

3.  Comparison of < 100 cc prostates and > 100 cc prostates undergoing aquablation for benign prostatic hyperplasia.

Authors:  N Bhojani; D-D Nguyen; R P Kaufman; D Elterman; K C Zorn
Journal:  World J Urol       Date:  2018-10-28       Impact factor: 4.226

Review 4.  Reasons to overthrow TURP: bring on Aquablation.

Authors:  Iman Sadri; Adel Arezki; Félix Couture; David-Dan Nguyen; Russell Schwartz; Ahmed S Zakaria; Dean Elterman; Enrique Rijo; Vincent Misrai; Thorsten Bach; Claus G Roehrborn; Kevin C Zorn
Journal:  World J Urol       Date:  2020-08-01       Impact factor: 4.226

5.  Comparison of the efficacy and safety of transurethral laser versus open prostatectomy for patients with large-sized benign prostatic hyperplasia: A meta-analysis of comparative trials.

Authors:  Hai-Bin Wei; Bing-Yi Guo; Yao-Fen Tu; Xuan-Han Hu; Wei Zheng; Da-Hong Zhang; Jian Zhuo
Journal:  Investig Clin Urol       Date:  2022-04-12

6.  Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates.

Authors:  David-Dan Nguyen; Neil Barber; Mo Bidair; Peter Gilling; Paul Anderson; Kevin C Zorn; Gopal Badlani; Mitch Humphreys; Steven Kaplan; Ronald Kaufman; Alan So; Ryan Paterson; Larry Goldenberg; Dean Elterman; Mihir Desai; Jim Lingeman; Claus Roehrborn; Naeem Bhojani
Journal:  BJU Int       Date:  2019-11-08       Impact factor: 5.588

7.  Photoselective sharp enucleation of the prostate with a front-firing 532-nm laser: an innovative surgical technique for benign prostatic hyperplasia-a single-center study of 475 cases.

Authors:  Yongquan Wang; Zhengchao Liu; Tao Jiang; Xiaozhou Zhou; Zhipeng Chen; Jun Zheng; Dishi Yan; Yuanxiu Zhou; Zhansong Zhou; Wenhao Shen
Journal:  World J Urol       Date:  2021-01-03       Impact factor: 4.226

8.  Impact of the presence of a median lobe on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of the Global Greenlight Group (GGG) Database.

Authors:  David-Dan Nguyen; Iman Sadri; Kyle Law; Naeem Bhojani; Dean S Elterman; Ahmed S Zakaria; Adel Arezki; Franck Bruyère; Luca Cindolo; Giovanni Ferrari; Carlos Vasquez-Lastra; Tiago Borelli-Bovo; Edgardo F Becher; Hannes Cash; Maximillian Reimann; Enrique Rijo; Vincent Misrai; Kevin C Zorn
Journal:  World J Urol       Date:  2021-01-03       Impact factor: 4.226

Review 9.  Recent advances in prostatectomy for benign prostatic hyperplasia.

Authors:  Alexis E Te
Journal:  F1000Res       Date:  2019-08-29

10.  WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm3 and 80-150-cm3 Prostates.

Authors:  David-Dan Nguyen; Neil Barber; Mo Bidair; Peter Gilling; Paul Anderson; Kevin C Zorn; Gopal Badlani; Mitch Humphreys; Steven Kaplan; Ronald Kaufman; Alan So; Ryan Paterson; Larry Goldenberg; Dean Elterman; Mihir Desai; Jim Lingeman; Claus Roehrborn; Naeem Bhojani
Journal:  Eur Urol Open Sci       Date:  2021-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.